The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
It’s hardly surprising then, that one of the biggest listed company buyouts of 2013 – and one of only a handful with a value of £1bn – has a distinctly TMT slant. Perhaps more surprising, is that it’s for one of the world’s biggest pharma companies.
It’s reportedly part of the pharma company’s strategy to diversify its offering. Alongside cancer drugs and lab equipment, Merck is already the world’s largest manufacturer of liquid crystals, which are used in TV’s, tablets and smartphones.
It is thought that picking up British company AZ Electronics will help the German giant to expand in the touch-screen market.
Allen & Overy has taken a lead role for longstanding client Merck, led by corporate partners Richard Browne and Michael Ulmer.
Clifford Chance represented AZ, with corporate partner Tim Lewis taking the helm. Meanwhile, Ashurst has been instructed by Merck’s financial advisor Bank of America Merrill Lynch.
Whatever the outcome of the bid, it’s clear that TMT is the place to be.